Neuro-linguistic programming for the treatment of adults with post-traumatic stress disorder, general anxiety disorder, or depression: a review of clinical effectiveness and guidelines

Canadian Agency for Drugs and Technologies in Health (CADTH)
Record ID 32015000827
English
Authors' recommendations: No clinical evidence on NLP for the treatment of adults with PTSD, GAD, or depression was identified. A SIGN (Scottish Intercollegiate Guidelines Network) guideline reported that no evidence specific to depression and meeting guideline inclusion criteria was identified on the use of NLP.
Details
Project Status: Completed
Year Published: 2014
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Canada
MeSH Terms
  • Neurolinguistic Programming
  • Anxiety Disorders
  • Depression
  • Depressive Disorder
Contact
Organisation Name: Canadian Agency for Drugs and Technologies in Health
Contact Address: 600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name: requests@cadth.ca
Contact Email: requests@cadth.ca
Copyright: Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.